Drug
GV101 clinical trials
Also written GV101.
- studies test it
- 3
- open now
- 1
- in phase 3
- 0
- first study started
- 2021
Keep track of what changes. Save the GV101 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
3 studies that test it; most in 2021 (1)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Graviton Bioscience Corporation (3)
Studies
Open first, then newest update. How each study uses GV101 is read from its arms, and is right about nine times in ten.
Testing it · 3
- GV101 for Friedreich's Ataxia (FA) TreatmentNot yet recruitingPhase 2Graviton Bioscience CorporationNCT07870590Written as GV101
- GV101 in Healthy Obese ParticipantsCompletedPhase 2Graviton Bioscience CorporationNCT06979505Written as GV101
- Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Dose of GV101 in Healthy SubjectsCompletedPhase 1Graviton Bioscience CorporationNCT05068947Written as GV101